Tivic Health Systems Inc (TIVC)

Form 8-K - Current report

Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model

Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage...

Form PRE 14A - Other preliminary proxy statements

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Tivic Health Selected to Present Entolimod™ as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7th

Tivic Health Selected to Present Entolimod™ as a Radiation Countermeasure and its Plans for an Oral...

Form S-1 - General form for registration of securities under the Securities Act of 1933

Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod

SAN ANTONIO, TX / ACCESS Newswire / March 31, 2026 / Tivic Health Systems, Inc. (Nasdaq:TIVC), a clinical-stage immunotherapeutics company, today...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual Conference

Presentation will Cover Recent Corporate Milestones Including Securing Agreement with NIAID SAN ANTONIO, TX / ACCESS Newswire / March 27, 2026 /...

Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome

Armed Forces Radiobiology Research Institute (AFRRI) Will Conduct the Gastrointestinal Acute Radiation Syndrome (GI-ARS) Study SAN ANTONIO, TX /...

Form 8-K - Current report

Tivic Reports Full Year 2025 Results

Completes Strategic Transformation into an Immunotherapy Company and Continues to Advance Entolimod Platform Toward Potential Funding...

Tivic Health CEO Letter to Shareholders

SAN ANTONIO, TX / ACCESS Newswire / March 24, 2026 / Tivic Health Systems (Nasdaq:TIVC)Dear Valued Shareholders,As I assume the role of Chief...

Form 8-K - Current report